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Abstract
Research on guided bone regeneration (GBR) is still ongoing, with evidence mainly from preclinical studies. Various current barrier membranes
should fulfill the main design criteria for GBR, such as biocompatibility, occlusivity, spaciousness, clinical manageability and the appropriate
integration with the surrounding tissue. These GBR characteristics are required to provide the maximum membrane function and mechanical
support to the tissue during bone formation. In this review, various commercially available, resorbable and non-resorbable membranes with
different characteristics are discussed and summarized for their usefulness in preclinical studies. Membranes offer promising solutions in animal
models; however, an ideal membrane has not been established yet for clinical applications. Every membrane type presents both advantages and
disadvantages. Titanium mesh membranes offer superb mechanical properties for GBR treatment and its current efficacy in trials will be a focus in
this review. A thorough understanding of the benefits and limitations inherent to various materials in specific clinical applications will be of great
value and aid in the selection of an optimal membrane for GBR.
# 2013 Japan Prosthodontic Society. Published by Elsevier Ireland.   
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Adequate bone volume is an important prerequisite for a
predictable, long-term prognosis in implant dentistry. However,
some patients present with insufficient horizontal or vertical
bone, which frequently precludes the successful outcome of an
ideal implant placement (Fig. 1). Various methods have been
developed to increase bone volume and augment new tissue
growth: (1) Distraction osteogenesis, which describes the
surgical induction of a fracture and the subsequent gradual
separation of the two bone ends to create spontaneous bone
regeneration between the two fragments [1]; (2) Osteoinduction,
which employs appropriate growth factors and/or stem/
osteoprogenitor cells to encourage new bone formation [2–4];
(3) Osteoconduction, in which a grafting material serves as a
scaffold for new bone formation [5]; and (4) Guided bone
regeneration (GBR), which provides spaces using barrier
membranes that are to be subsequently filled with new bone [6,7].
Most biochemical osteoinductive approaches still have an
extremely limited clinical application, such as the use of bone
morphogenetic proteins (BMPs) [8]. In addition, in certain
locations, such as in the jaw, distraction osteogenesis is still in
its development phase and often leaves undesirable tissue
scarring [9]. This leaves GBR and the use of bone grafting
materials or combinations of these methods as the only ones
commonly applied in clinical practice. GBR is reported as
providing the best and the most predictable results when
employed to fill peri-implant bone defects with new bone
[6,7,10]. Furthermore, GBR improves the predictability of bone
augmentation and provides long-term stability to the newly
augmented site [11,12].
2. Principles of guided bone regeneration
The underlying concept of GBR was first introduced more
than 50 years ago, when cellulose acetate filters were
experimentally used for the regeneration of nerves and tendons
[13]. Subsequently, cellulose acetate (MilliporeTM membrane
filter) enhanced osseous healing of rib, radial bone and femoral
bone defects [14]. Later, a series of animal studies provided
evidence to show that GBR can predictably facilitate bone
regeneration in critical-sized osseous defects [15–20], as well
as the healing of bone defects around dental implants by
augmenting the height and the width of atrophic alveolar ridges
prior to implant insertion [21–26].
The basic principle of GBR (Fig. 2) involves the placement
of mechanical barriers to protect blood clots and to isolate the
bone defect from the surrounding connective tissue, thus
providing bone-forming cells with access to a secluded space
intended for bone regeneration [27]. According to this
principle, the use of a barrier membrane is advantageous tofacilitate augmentation of alveolar ridge defects, induce bone
regeneration, improve bone-grafting results, and treat failing
implants [28].
3. Design criteria for GBR membrane
In addition to the surgical technique used, there are many
factors that contribute to a successful GBR outcome, including
barrier occlusion and stability, the size of the barrier
perforations, peripheral sealing between the barrier and the
host bone, an adequate blood supply, and access to bone-
forming cells [29–35]. Moreover, in the last few years, several
membrane designs have been studied that not only enhance new
bone formation, but also stabilize the bone graft below the
membrane and minimize the risk of collapse and/or soft tissue
ingrowth (Table 1) [19,25,31,32,36–48].
For use as a medical device, barrier membranes must fulfill
five main design criteria, as described by Scantlebury [49]:
biocompatibility, space-making, cell-occlusiveness, tissue
integration and clinical manageability.
3.1. Biocompatibility
The membrane must provide an acceptable level of
biocompatibility. The interaction between the material and
tissue should not adversely affect the surrounding tissue, the
intended healing result, or the overall safety of the patient.
3.2. Create a space for ingrowth
The membrane should have an adequate stiffness to create
and maintain a suitable space for the intended osseous
regeneration. This quality is predominantly related to the
membrane thickness. In addition, a membrane should provide
an optimal space that can be maintained for tissue ingrowth but
also still provide adequate support to the tissue, even in large
defects. The material should also be appropriately malleable to
provide the specific geometry required for functional recon-
struction, but be sufficiently stiff to withstand the pressures
exerted by external forces, such as mastication in jaw
reconstructions [50]. If the membrane were to collapse into
the defect space, the volume for regeneration is reduced and an
optimal clinical outcome would not be achieved.
3.3. Occlusivity
An optimal barrier should be sufficiently occlusive to avoid
fibrous tissue formation, which may prevent or delay bone
formation. Occlusivity is therefore closely linked to membrane
porosity; this factor has a major influence on the potential for
cell invasion [46]. Indeed, barrier occlusivity of a membrane
Fig. 1. (a) An adequate bone volume (height and width) is a prerequisite for successful implant treatment. (b) Barrier membrane and bone graft as bone substitute
materials are placed to accelerate bone formation. (c) After new bone is formed final prosthesis is fabricated.
Fig. 2. The principle of guided bone regeneration using mechanical barriers
(membranes) to seal off the bone defect from the surrounding soft connective
tissue into a secluded space by which cells only from the surrounding bone can
migrate.
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when regenerating bone defects [51].
The architecture of the porous structures in general, and not
the type of material used, has been suggested to confer the
biological activity of a material [52]. Membrane pores
facilitate the diffusion of fluids, oxygen, nutrients and
bioactive substances for cell growth, which is vital for
bone and soft tissue regeneration. However, these pores
must also be impermeable to epithelial cells or gingival
fibroblasts (in the case of dental implants); a larger pore
size will allow these faster-growing cells to overpopulate
the defect space and inhibit the infiltration and activity of
bone-forming cells [50]. A larger pore size also acts an
easy pathway for bacterial contamination, and surgical
removal of these contaminated membranes becomes
complicated because of the excess soft tissue ingrowth
[53,54]. If pores are too small, on the other hand, cell
migration of all cells is limited, which leads to enhancedcollagen deposition, the formation of avascular tissue, and
an absence of capillary growth and infiltration [55]. Pore
size will also affect the capacity of the material to support
the tissue. A large pore size will inevitably decrease the
resulting surface area of the material, which could limit
the important initial steps of cell adhesion onto the
membrane [56] and subsequent decrease of blood vessel
ingrowth [53].
3.4. Tissue integration
Tissue integration is the key aspect of all tissue regeneration
techniques as it is essential that the host tissue integrates with
the membrane. It is well established that the structural integrity
of the barrier membrane and the sufficient adaptability of its
borders to the adjacent original bone constitute prerequisites for
predictable new bone formation [29]. Tissue integration
stabilizes the healing wound process, and helps to create a
seal between the bone and the material to prevent fibrous
connective tissue integration into the defect site. Tissue
integration between the membrane and the contours of the
adjacent bone is reliant on the membrane space-making
capacity of the material; a material that is too stiff would not be
able to mold to the shape of the defect site.
3.5. Clinical manageability
A membrane should be practical for clinical use,
particularly for dental work. A membrane that is difficult
to use, such as one that is too malleable, can be frustrating
and will often lead to complications if it cannot be
reproducibly used in a clinical setting, particularly the
usually small setting inherent with dental implants [50]. On
Table 1
Summary of studies using GBR membranes with different membrane structures and designs.
Year [Ref]
Author
Animal model Type of membrane Study design Assessment Outcome
2012 [36]
Rothamel
Dog maxilla Remotis (multilayered with
interconnected system of
pores); BioGide (bilayer
structure, smooth upper surface
and coarser bottom surface)
Histological evaluation
at 4, 8, 12 and 24 weeks
Biodegradation and bone
formation
Remotis: an interconnective pore system, Bio-Gide: more
fibrous structure. Both membranes integrated into the
surrounding tissue without any inflammatory infection,
allowed early vascularization and supported underlying
bone formation. Biodegradation: Remotis (8–12 weeks);
Bio-Gide: 4–8 weeks.
2010 [37]
de Santana
Mouse calvaria Synthetic polylactide SEM; histological and morphometric
evaluation at 14 and 28 days
Topographic (porosity of
membrane); bone formation
Interconnecting pores and channels (F: 6–60 mm), with
smooth internal walls. Different sides of the barrier promote
differential soft tissue responses; however, similar amounts
of enhanced bone formation.
2009 [38]
Gutta
Dog mandible Ti meshes (macro: 1.2 mm;
micro: 6 mm porous);
polylactic acid (1 mm porous)
Histological and morphometric
evaluation at 1, 2, and 4 months
Bone growth and soft tissue
ingrowth area; MAR
Macroporous membrane: greater bone regeneration,
prevented significant soft tissue ingrowth, the lowest MAR
compared with microporous and Polylactic acid.
2008 [39]
Sverzut
Dog mandible RIF, BG, MI, MI + BG, MIP,
MIP + BG
Histological and morphometric
evaluation at 6 months
Bone area MI + BG: larger amounts of bone compared with other
groups. MIP alone and BG alone: no difference. MI: the least
bone area and reduced the amount of grafted bone.
2004 [40]
Polimeni
Dog mandible e-PTFE (15–25 mm pore size
and reinforced with
polyprophylene mesh) and the
300 mm porous devices
Histological and morphometric
evaluation at 8 weeks
Bone regeneration (height);
wound area; bone width
Occlusive and porous GTR; both space-provision and device
occlusivity; occlusive and space-provision compared to sites
with porous GTR device or more limited space-provision:
significant bone regeneration.
2004 [41]
Polimeni
Dog mandible e-PTFE membranes (15–25 mm
pore size); calcium carbonate
CI (resorbable, porous)
Histological and morphometric
evaluation at 4 weeks
Bone regeneration (height);
wound area
Space-provision: significant effect on bone regeneration
following GTR. Coral biomaterial: enhances space-provision
and supports bone regeneration.
2003 [42]
Van Steenberghe
Rabbit skull Titanium barriers dome shaped
(w: 12 mm; height: 6 mm;
thickness: 0.2 mm)
Microradiograph; histological
evaluation at 3, 6 and 12 months
Area of tissue; area of
trabeculae; mean trabeculae in
dome
The bone grew systematically along the titanium surface.
After removal of the barrier, on average 75.3% and 59.4% of
the newly created tissue volume was maintained after 3 and
9 months, respectively.
2003 [43]
Mardas
Rat mand. ramus Hemisperical teflon packed
with DBM. Test capsules:
9 perforations; w: 0.3 mm.
Contralateral side: non
perforated (cell occlusive)
Histological evaluation;
planimetric measurement
at 30, 60 and 120 days
The space in the capsule; newly
formed bone; DBM particles;
loose connective tissue
In cell-permeable and cell-occlusive capsules grafted with
DBM: similar amounts of bone formed. Invasion of
undifferentiated mesenchymal cells from the surrounding
soft tissues into the barrier-protected area is unnecessary for
bone formation with GTR.
2003 [44]
Yamada
Rabbit calvaria Hemispherical cap of titanium.
One cap had small holes (13
holes, w holes: 1.5 mm) and the
other had no holes
Histological evaluation
at 1 and 3 months
Areas of newly generated tissue
(%) and mineralized bone in the
newly generated tissue under
the Ti cap
Statistically significant difference: the amount of tissue
generated between 1 and 3 months; the amount of
mineralized bone generated at 3 months under the cap
without holes. Total occlusiveness, sufficient stiffness and
passage of time allow predictable mineralized bone
augmentation.
2000 [19]
Marouf
Rabbit calvaria High density PTFE (TefGen-FD);
semipermeable e-PTFE (Gore-
Tex)
Histological and morphologic
evaluation at 4, 8 and 16 weeks
Pattern of bone healing by
morphological classification
TefGen: easier to detach from the underlying bone than GT.
GBR: GT is more effective than TefGen-FD. GT membrane
lamellae were infiltrated by fibro-osseous tissue.
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Table 1 (Continued )
Year [Ref]
Author
Animal model Type of membrane Study design Assessment Outcome
1999 [45]
Simion
Dog mandible Ti reinforced e-PTFE: GTRM
1; GTRM 2; GTRM 3
Histological and morphometric
evaluation
Regenerated tissue, membrane
contact with regenerated bone
or with bone
An extremely open porous microstructure + a totally
occlusive barrier: significant regenerative outcomes.
However, these design may be applied only to resorbable
devices. Do not require removal.
1998 [32]
Lundgren
Rat calvaria Prefabricated silicone
frames + 7 barriers with
different occlusiveness (a stiff
plastic plate and 6 polyester
meshes, perforation: 10, 25, 50,
75, 100 and 300 mm)
Histological and morphometric
evaluation at 4, 8 and 12 weeks
Total area of tissue and total
area of mineralized bone
Totally occlusive barriers: the slowest rate of bone tissue
augmentation. Barriers with perforations >10 mm: faster
rate of bone augmentation. The amount of augmented
mineralized bone related to perforation sizes >10 mm: no
differences.
1998 [31]
Lundgren
Rabbit; edent.
area of the maxilla
Gore-Tex augmentation
material (GTAM); non
perforated titanium foil;
perforated titanium foil
Histological and morphometric
evaluation at 4 weeks
Total of original bone area;
remaining bone area;
mineralized bone; cortical
and trabeculae bone;
bone marrow
The highest degree of regeneration: in defects underneath
the titanium foils, particularly if perforated (covered/not by
GTAM-barriers). The space maintaining properties of a
barrier may be at least as important as barrier occlusiveness
when regenerating bone defects.
1997 [46]
Salzmann
Rat subcut. tissue
and epididymal
fat pads
e-PTFE of 30, 60, 100 mm
structural differences
Histological and
immunohistochemical
examination at 5 weeks
Fibrous capsule formation,
endothelialization and activated
monocytes and macrophages
30 mm subcutaneous implants: dense fibrous capsule
formation. 60 mm: the greatest endothelialization. 100 mm:
the largest values for the Monocyte/Macrophage Index.
Material structure and implant site influence the healing of
ePTFE. Activated monocytes/macrophages may inhibit
endothelialization of e-PTFE.
1996 [47]
Zellin
Rat calvaria Dome-shaped e-PTFE
membranes with different
membrane porosity: <8, 20–25
and 100 mm
Histological and morphometric
evaluation at 6, 12, 18 weeks
and 6 months
Percentage bone fill of domes The amount of new bone: at 6 weeks essentially obtained
with the two most porous membranes compared to the least
porous; at 12 weeks: no difference. The smallest internodal
distance: lack of membrane stabilization and more soft
tissue ingrowth from the side.
1995 [25]
Zellin
Rat mand. ramus Resorbable: Guidor, Periogen,
Resolut LT, Resolut ST, Vicryl
C, Vicryl PM; non resorbable:
GTAM, Millipore (pore
size:0.22 mm), NYT, Ti-foil
(50 mm gauge)
Histological evaluation Numerical score of blood clot,
bone union, compact bone, bone
marrow, inflammatory response
GTAM, Millipore and Resolut ‘long term’: good
osteopromotive effect compared to others membranes.
Inflammatory reaction was displayed in the surrounding
soft tissue. Different membranes differ strongly in
osteopromotive efficacy. Membranes developed primarily
for periodontal regeneration purposes may not be adequate
to promote bone healing.
1994 [48]
Schmid
Rabbit calvaria Titanium cast gold device (2
tubes). 1 tube: closed by the
cast metal, 1 tube: covered
by an e-PTFE with 4 different
structures (GT Periodontal;
GTAM center part; GTAM
outer part; GT RC-10
Histological evaluation at 8
months
Bone formation area in the
cylinders irrespective of
whether the chamber was
sealed off by cast titanium or
the e-PTFE membrane
After 8 months of healing, new bone had formed in all
cylinders in all animals irrespective of whether the chamber
for bone formation was sealed off by cast titanium or the
ePTFE membrane. It is concluded that permeability of the
membrane is not necessary in the guided generation of new
bone.
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Table 2
Typical commercially available membranes.
Commercial name Properties (pores; thick) Comments
Non resorbable expanded polytetrafluoroethylene (e-PTFE)
Gore-Tex1 0.5–30 mm. Discontinued Longest studies [59–63]
Non resorbable high dense polytetrafluoroethylene (d-PTFE)
CytoplastTM (GBR; TXT) Less than 0.3 mm Primary closure unnecessary [64,65]
Cytoplast1Non Resorb Less than 1.36 mm Favorable bone regeneration [61]
TefGen FDTM 0.2–0.3 mm Easy to detach [19,54]
Nonresorbable ACE <0.2 mm; 0.2 mm Limited cell proliferation [66]
Non resorbable titanium mesh
Frios1BoneShields 0.03 mm; 0.1 mm Sufficient bone and graft maturity [67,68]
Tocksystem MeshTM 0.1–6.5 mm; 0.1 mm No sign of inflammation/resorption [68]
M-TAMTM 1700 mm; 0.1–0.3 mm Excellent tissue compatibility [69]
Ti-Micromesh ACE 1700 mm; 0.1 mm Long term survival and success rate [70]
Resorbable collagen (origin type of collagen; resorption time)
BioGide1 Porcine (I and III); 24 weeks Useful alternative to e-PTFE [71]
BioMend1 Bovine (I); 8 weeks Bone growth, modulate cell behaviors [72,73]
Biosorb1 Membrane Bovine (I); 26–38 weeks Provided stable fixation [74]
NeomemTM Bovine (I); 26–38 weeks Two layers, used in severe case [75]
OsseoGuard1 Bovine (I); 24–32 weeks Improves aesthetic outcome [76]
Ossix Porcine (I); 16–24 weeks Increased the woven bone [77]
Resorbable synthetic (origin; resorption time)
Atrisorb1 Poly-DL-lactide; 36–48 weeks Custom fabricated membrane [78]
Biofix1 Polyglycolic acid; 24–48 weeks Act as barrier to gingival cells and bacteria [79]
Epiguide1 Poly-DL-lactic acid; 24–48 weeks Support developed blood clot [73]
Resolut XT Poly-DL-lactide/Co-glycolide; 8 weeks Porous structure influence the cells attached [73]
OsseoQuest1 Hydrolyzable Polyester; 16–24 weeks Good tissue integration [80]
Vicryl Polyglactin 910 mesh; 8 weeks Most reliable results compared with non-resorbable [72]
Y.D. Rakhmatia et al. / Journal of Prosthodontic Research 57 (2013) 3–148the other hand, a membrane that is too stiff cannot be
contoured easily, and the sharp edges could perforate the
gingival tissue and subsequent exposure of the membrane
[57]. One study showed that non-resorbable barriers
provided a suitable stiffness over resorbable membranes
for optimal bone width and height in GBR [58].
4. Barrier membranes for GBR
Numerous barrier membranes have been developed to serve
a variety of functions in clinical applications, which can be
grouped as resorbable or non-resorbable membranes. The
biomaterial and physical properties of membranes ultimately
influence their function, and selection of a specific material is
based on the biological properties of the membrane as well as
the treatment requirements [59], with each material bearing
inherent advantages and disadvantages. Several of the
commercially available membranes are summarized in Table
2 [19,54,59–80].
4.1. Resorbable membranes
Resorbable materials that are used as membranes all belong
to the groups of natural or synthetic polymers. Of these,
collagen and aliphatic polyesters, such as polyglycolide or
polylactide, are best known for their medical applicability [81].
Collagen is derived from a number of sources and is treated in
various ways for membrane fabrication. Polyglycolide orpolylactide can be made in large quantities, and the wide range
of available materials allows for the creation of a wide spectrum
of membranes with different physical, chemical, and mechan-
ical properties [82].
As the name suggests, resorbable materials offer the
advantage of being resorbed by the body, thus eliminating
the need for second-stage removal surgery. For this reason,
resorbable membranes appeal to both clinician and patients, in
reducing the risk of morbidity, the risk of tissue damage, and
from a cost-benefit point of view. In principle, stiff resorbable
membranes promote a similar degree of bone regeneration and
bone formation as non-resorbable membranes [83,84]. More-
over, in situations where the bone defect margins are
appropriately maintained by the membrane, favorable results
have been reported [85,86].
The disadvantages of resorbable materials, however, are their
unpredictable degree of resorption, which can significantly alter
the amount of bone formation [72]. If they are resorbed too fast,
the consequential lack of rigidity means that additional support is
required [38,87]. They also have shortcomings when trying to
protect large particulate grafts [60]. When the membranes are
exposed and/or associated with inflammatory reactions in the
adjacent tissue, the enzymatic activity of macrophages and
neutrophils causes the membrane to rapidly degree, thereby
affecting the structural integrity of the membrane and causing
decreased barrier function and less bone regeneration or bone fill;
this is particularly problematic when grafting in conjunction with
implant placement, as the implant becomes unstable [88]. When
Y.D. Rakhmatia et al. / Journal of Prosthodontic Research 57 (2013) 3–14 9the bone defect is not supported by a physical barrier, bone
regeneration fails. Even if the membranes are initially able to
keep the space, they generally lose strength, collapse into the
space and lead to a failed reconstruction [25]; for example, when
treating periodontal defects, resorbable membrane may have a
tendency to collapse [89].
4.2. Non-resorbable membranes
Non-resorbable membranes include polytetrafluoroethylene
(PTFE) and titanium mesh. One drawback in the use of this type
of membrane is the necessity for its removal with a second-
stage surgical procedure. However, this disadvantage may be
overshadowed by the advantages offered. These membranes
provide an effective barrier function in terms of biocompat-
ibility [86], they can maintain the space beneath the membrane
for a sufficient period, they are more predictable in their
performance, they have a reduced risk of long-term complica-
tions, and they are simple to manage clinically [90]. Non-
resorbable membranes also offer a unique characteristic. Their
structure can be varied with changes in porosity if a more
adaptable and tissue-compatible alternative, and multiple
designs are commercially available and can be further
developed on demand [59]. We will discuss three predominant
non-resorbable membranes: the expanded and dense forms of
PTFE (e- and d-PTFE) and titanium mesh.
4.2.1. e-PTFE membrane
According to its structure, PTFE can be divided into two
types: expanded-PTFE (e-PTFE) and high density-PTFE (d-
PTFE). The Gore-Tex1 membrane (W.L. Gore & Associates,
Flagstaff, AZ, USA), which is composed of e-PTFE, has been
widely used in clinical treatment and had become a first choice
material for tissue/bone regeneration. It is also used extensively
for digestive, cerebral and cardio-vascular surgeries, and basic
research has indicated its effectiveness in tissue-guided repair
[61]. Indeed, in a recent controlled study [63], it was shown that
a combination of an e-PTFE membrane and autogenous bone
graft at edentulous sites may limit graft resorption, thus
enhancing bone repair.
e-PTFE membrane has two different microstructures: a
coronal border and an occlusive portion. The coronal border,
with internodal distance of 25 mm, has an open microstructure
collar that facilitates early clot formation and collagen fiber
attachment to stabilize the membrane until it becomes fixed
[59,61]. The occlusive portion has an internodal distance of
less than 8 mm to allow nutrient inflow while preventing the
infiltration of other tissue cell types [59]. e-PTFE comprises
numerous small pores, which encourage tissue cell attachment
that stabilizes the host-tissue interface. These smaller pores
also act to restrict the migration of epithelial cells [62].
However, this material requires second-stage surgical extrac-
tion, which may expose the membrane to bacteria [60].
Furthermore, e-PTFE must be removed immediately in the
case of inflammation. At present, e-PTFE membrane has been
discontinued and is not available for dental use; however,
possible alternatives are available.4.2.2. d-PTFE membrane
High density PTFE (d-PTFE) membrane (ex. CytoplastTM
Regentex GBR-200 or TXT-200; Osteogenics Biomedical Inc.,
Lubbock, Texas, USA) is one alternative to e-PTFE. This
membrane was originally developed in 1993, and its success in
bone and tissue regeneration is well documented [64,65]. This
membrane is made of a high-density PTFE, with a submicron
(0.2 mm) pore size. Because of this high density and small pore
size, bacterial infiltration into the bone augmentation site is
eliminated, which protects the underlying graft material and/or
implant. Furthermore, primary soft tissue closure is not
required [54,65]. Previous authors have reported that d-PTFE
completely blocks the penetration of food and bacteria, and
thus, even if it is exposed to the oral cavity, it is still acts as an
appropriate membrane barrier [91,92]. Interestingly, one of the
materials, CytoplastTM, does not have porous structure and its
attachment to tissues is weak. Thus, it can be removed easily by
pulling on the membrane without lifting the mucosal flap. In
addition, even if it is exposed, the risk of infection is less than
that of e-PTFE [61].
4.2.3. Titanium mesh
Besides PTFE membranes, titanium is another non-
resorbable material applicable for dental bone repair. In
1969, Boyne et al. inaugurated a mesh from titanium for the
reconstruction of large discontinuity osseous defects [96].
Titanium has been used extensively in numerous surgical
applications because of its high strength and rigidity, its low
density and corresponding low weight, its ability to withstand
high temperatures and its resistance to corrosion [87,93,94].
This metal is highly reactive, and can be readily passivated to
form a protective oxide layer, which accounts for its high
corrosion resistance [95]. The low density of titanium provides
both high-strength and lightweight dental materials [95].
5. Focus on titanium mesh and its role in GBR
Research into GBR is still ongoing and evidence for the use
of titanium in dental applications is expanding, particularly for
alveolar ridge reconstruction prior to implant placement. We
searched the PubMed Medline databases from 1991 to 2011 and
retrieved all relevant articles (in English only) reporting the use
of titanium mesh for bone regeneration in the clinic, using
various search terms (membrane/gbr/bone regeneration/tita-
nium mesh/titanium membrane). The study summaries are
shown in Table 3 [35,60,68–70,94,97–107].
Titanium mesh (Ti-mesh) has excellent mechanical proper-
ties for the stabilization of bone grafts beneath the membrane.
Its rigidity provides extensive space maintenance and prevents
contour collapse; its elasticity prevents mucosal compression;
its stability prevents graft displacement; and its plasticity
permits bending, contouring, and adaptation to any unique bony
defect [60,97]. Various studies have shown that Ti-mesh
maintains space with a higher degree of predictably, even in
cases with a large bony cavity [57,71,108,109]. In addition, it is
believed that the smooth surface of Ti-mesh makes it less
susceptible to bacterial contamination than resorbable materials
Table 3
Summary of clinical studies with titanium mesh membranes prior to implant placement.
Study Titanium mesh No. of patients Defect type Bone Grafts Bone (%) Infection, Exposures,
or Removal
Implant placement
(months)
No. of
implants
Implant survival
(follow-up)
2012 [97]
Her
MTAM 0.1-mm-thick;
w pores: 1.7 mm
27 Alveolar ridge max
and mand
Bone Graft Material 85.18 Exposure: 26% 5.7 69 100% (2 years)
2010 [98]
Torres
Ti-mesh 15: mesh only;
15: mesh + PRP
Edentulous ridge
max and mand
Anorganic bovine bone 100 Exposure: 28.5%
(Ti mesh only)
6 97 Mesh only: 97.3%;
Mesh + PRP:
100% (2 years)
2009 [70]
Corinaldesi
ACE 24 Alveolar ridge Mand ramus 85 Exposure and
removal: 14.8%
8–9 56 100% (3–8 years)
2008 [99]
Louis
Ridge Form Mesh 44 Alveolar ridge max
and mand
Illiac crest/tibia/mand. +
hydroxyapatite
97.72 Exposure: 52.7%
Removal: 7
Failed placement: 1
6.9 174 ND
2007 [100]
Roccuzzo
Micro Dynamic Mesh 23 Edentulous ridge max
and mand
Mand ramus or mental
symphysis
83.33 Exposure: 33.33%
(4 from 12 sites)
Removal: 8.33%
4–6 24 ND
2006 [101]
Molly
Custom fit 11 Max Hip onlay grafts 54 Exposure: 5 (bone was
formed enough)
9–17 Ant: 30
Post: 16
Ant: 82.6% (9 years);
Post: 76.6% (6 years)
2006 [68]
Proussaefs
Frios 17 Alveolar ridge max
and mand
Chin, ramus, extra socket,
Max tuber + Bio-Oss
73 Exposure: 35.3% 8.47 41 71% (6 months)
2004 [35]
Roccuzzo
Micro Dynamic and
Modus 1, 5
18 Edentulous ridge max
and mand
Mand ramus or mental
symphysis
83.33 Exposure: 22.22%
Temporary paresthesia:
27.77%
4–6 37 100% (2 months)
2003 [102]
Artzi
CTM 10 Alveolar ridge Bovine bone mineral 81.2 Exposure: 20% 9 10 ND
2003 [94]
Degidi
Cortical Mesh 18 Alveolar ridge No 100 No 4–6 50 100% (7 years)
2002 [103]
Lozada
Sofamor Danek 1 Edentulous ridge Iliac crest 100 No 7 Max (10),
Mand (6)
ND
2001 [104]
Assenza
Bonesheet + e-PTFE 22 Alveolar ridge No 81.8 Exposure: 4 sites
Removal: 2 sites
Max (6),
Mand (4)
22 ND
2001 [105]
Maiorana
0.2-mm-thick Ti-mesh 14 Edentulous Illiac and anorganic
bovine bone
100 Exposure: 14.28% 4–5 59 98.3% (4 years)
1999 [106]
von Arx
M-TAM 15 Alveolar ridge Cancellous bone 93.5 Exposure and
removal: 1 sites
5–10 20 ND
1998 [69]
Malchiodi
Tocksystem 80 mm
microhole
25 Edentulous ridge max Retromolar mand 96 Dehiscence: 3 implants
(1 patient)
8 120 ND
1998 [107]
von Arx
M-TAM 18 Alveolar ridges Retromolar area and chin 100 No 5.2 27 100% (1–3 years)
1996 [60]
von Arx
M-TAM 20 Alveolar ridge Retromolar area, impacted
canine, chin
90 Exposure: 50%
Removal: 1 patient
6–8 28 ND
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resorbable membranes are a possible nidus for infection, and
microbial colonization within superficial and deep portions of
membrane is favored [110,111].
However, the stiffness of the Ti-mesh also lends itself to
causing an increased number of exposures, such as mechanical
irritation to the mucosal flaps [112]. In addition, the sharp
edges, caused by cutting, trimming, and bending of titanium
mesh, might be responsible for exposure of titanium barriers
[57]. Despite the exposure, von Arx et al. noticed no infection in
any of their patients [60]. This offers an advantage as compared
with e-PTFE barriers, which result in infection when exposed
[113,114].
The superb properties of Ti-mesh make it optimal for
successful GBR [35,70,94,98,105,107]. However, many pro-
blems still remain and need to be resolved to increase the
predictable nature of these materials. Most problems with Ti-
mesh arise from their exposure and from soft tissue ingrowth.
The stiffness of Ti-mesh can maintain space better than other
membrane, but may result in mucosal irritation that leads to
exposure of the membrane. This space maintenance and
resistance to collapse is influenced by the thickness of the Ti-
mesh, and as such, an appropriate thickness must be balanced
with the likelihood of irritation when using Ti-mesh for GBR.
Another common feature of commercially available Ti-
mesh membranes is its macroporosity (in the millimeter range).
This is thought to play a critical role in maintaining blood
supply and is believed to enhance regeneration by improving
wound stability through tissue integration and allowing
diffusion of extracellular nutrients across the membrane
[54,115,116]. Another advantage of this macroporosity is
related to the attachment of soft tissues, which may stabilize
and restrict the migration of epithelial cells [61,117,118].
However, this makes the material difficult to remove at the
second surgery. These macro- and multi-porous characteristics
also create sharp spots when the material is cut or bent, and may
provide an easy pathway for microbial contamination into the
healing site [94]. Thus, the development of less porous and
micropore-sized Ti-mesh membrane could alleviate some of
the current difficulties associated with Ti-mesh in dental
applications.
6. Conclusion
The concept of GBR for the reconstruction of the alveolar
ridge defect prior to implant placement has been developed in
an effort to optimize treatment strategies. Research from animal
and clinical studies in this field is still ongoing in order to
establish an ideal membrane for treatment. Since every
membrane offers both advantages and disadvantages, a
membrane should be selected based on a thorough under-
standing of the benefits and limitations inherent to the materials
in relation to the functional requirements in the specific clinical
application.
Titanium mesh offers an excellent solution for GBR in
dental applications over other membrane types. Preliminary
clinical studies have also shown its predictable nature in bothlateral and vertical bone augmentation. However, necessary
adjustments to the pore size and frequency in titanium mesh
biomaterials should improve their efficacy in dental applica-
tions.
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